These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 13765186)

  • 1. Treatment of Parkinson's disease with chlorphenoxamine.
    MAGEE KR; CURRIER RD
    J Mich State Med Soc; 1960 Sep; 59():1364-5. PubMed ID: 13765186
    [No Abstract]   [Full Text] [Related]  

  • 2. Chlorphenoxamine hydrochloride in parkinsonism. A controlled trial.
    ULDALL PR; WALTON JN; NEWELL DJ
    Br Med J; 1961 Jun; 1(5240):1649-52. PubMed ID: 13779077
    [No Abstract]   [Full Text] [Related]  

  • 3. [The present status of drug therapy of Parkinson's syndrome].
    von MONAKOW K
    Praxis; 1962 Jan; 51():30-3. PubMed ID: 14475321
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of paralysis agitans with chlorphenoxamine hydrochloride.
    DOSHAY LJ; CONSTABLE K
    J Am Med Assoc; 1959 May; 170(1):37-41. PubMed ID: 13640980
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the medicinal treatment of Parkinson's syndrome. Clinical experiences with disipal].
    MUELLER TH
    Wien Med Wochenschr; 1960 Apr; 110():357-60. PubMed ID: 14424966
    [No Abstract]   [Full Text] [Related]  

  • 6. The acute and chronic toxicities of chlorphenoxamine.
    KERLEY TL; NEWBERNE JW; BRINKMAN DC; WEAVER LC
    Toxicol Appl Pharmacol; 1962 Sep; 4():638-49. PubMed ID: 14455272
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experiences with a new substance for the suppression of Parkinson tremors].
    SCHULZ HP
    Med Klin; 1961 Dec; 56():2174-6. PubMed ID: 13909545
    [No Abstract]   [Full Text] [Related]  

  • 8. Akineton in the treatment of parkinsonism.
    O'DOHERTY DS; EDWARDS CE
    Med Ann Dist Columbia; 1960 Jul; 29():378-80. PubMed ID: 14428055
    [No Abstract]   [Full Text] [Related]  

  • 9. Mood elevating effects of chlorphenoxamine HCl.
    EISENBERG DM; ROZAN GH
    Am J Psychiatry; 1960 Aug; 117():155. PubMed ID: 13819745
    [No Abstract]   [Full Text] [Related]  

  • 10. A clinical assessment of orphenadrine (disipal) in the treatment of Parkinsonism.
    ROBINSON LR; DICK TH
    Ulster Med J; 1960 Jun; 29(1):64-9. PubMed ID: 14437972
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic experience with a new Hungarian drug parkazin in ambulatory practice].
    KLIMES K
    Orv Hetil; 1961 Oct; 102():2046-8. PubMed ID: 14456960
    [No Abstract]   [Full Text] [Related]  

  • 12. Biperiden (Akineton) in Parkinsonism.
    TIMBERLAKE WH; SCHWAB RS; ENGLAND AC
    Arch Neurol; 1961 Nov; 5():560-4. PubMed ID: 13921278
    [No Abstract]   [Full Text] [Related]  

  • 13. [A study on antiparkinson drugs with special reference to Kemadrin (procyclidine)].
    NAKAZAWA T; KASAHARA T; KOMIYA H
    No To Shinkei; 1962 May; 14():435-43. PubMed ID: 14478260
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinical evaluation of chlorphenoxamine with caffeine in the treatment of Parkinson's disease, including a comparison with methixene.
    Strang RR
    J Clin Pharmacol J New Drugs; 1967; 7(4):214-20. PubMed ID: 5340692
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical study on the combined action of orphenadrine and thioproperazine: correction of neuroleptic impregnation and therapeutic synergism].
    RUDRAUF J; CHALLOU C
    Acta Neurol Psychiatr Belg; 1961 Jan; 61():103-9. PubMed ID: 13744502
    [No Abstract]   [Full Text] [Related]  

  • 16. [Disipal and the correction of parkinsonism induced by neuroleptics. (A critical review)].
    MEURICE E
    Acta Neurol Psychiatr Belg; 1961 Jan; 61():47-66. PubMed ID: 13769933
    [No Abstract]   [Full Text] [Related]  

  • 17. [First results of a new treatment of Parkinson's disease and of parkinsonism; therapeutic effect of 3-phenyl-3-(beta-diethylamino-ethyl)-2, 6-dioxo piperidine alone and with reserpine and ritalin; preliminary note].
    GIANNIOTTI G; GIBERTI F; SPIZZIRRI S
    Gazz Med Ital; 1956 Mar; 115(3):71-4. PubMed ID: 13344883
    [No Abstract]   [Full Text] [Related]  

  • 18. The evaluation of imipramine in the treatment of Parkinson's disease.
    GILLHESPY RO; MUSTARD DM
    Br J Clin Pract; 1963 Apr; 17():205-8. PubMed ID: 13947924
    [No Abstract]   [Full Text] [Related]  

  • 19. [Trial treatment of urticaria with chlorphenoxamine].
    BAZEX A; DUPRE A; CHRISTOL B
    Clinique (Paris); 1963; 58():447-50. PubMed ID: 13967113
    [No Abstract]   [Full Text] [Related]  

  • 20. [Preliminary report on rigidyl therapy of extrapyramidal movement disorders].
    HANSEN B; TASCHABITSCHER H
    Wien Med Wochenschr; 1952 Jul; 102(29/30):551-4. PubMed ID: 12995613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.